Keyser Wednesday, 05/06/20 07:34:21 PM Re: None Post # of 291373 No matter how one feels about pursuing the Federal Circuit appeal to conclusion (my view is that Amarin has no practical choice and must see it to conclusion), I believe that the filing of its Opening Brief next week will give us all a boost of confidence. If the legal arguments are well presented, we may see a reasonable increase in current SP and there should be patent attorneys, both in the financial press and on this board, weighing in on the merits as presented. I understand that often appeals are determined by the composition of justices drawn for the panel, but there are times when a decision (LIKE DU's) is so destructive or out of line with the recognized legal standards and analysis, that justices on both sides of the aisle as of the view that it must be reversed. This may be one of those times. And, please recall, that later in the process (after the generics' brief(s) are filed, we likely will see significant amicus curiae briefs from the industry.